People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications.

A Milwaukee apartment building fire that began in a common area and spread to multiple floors Sunday killed four people and ...

Wall Street stock futures jumped and the dollar firmed against safe haven peers on Monday as signs of progress in U.S.-China ...